(VIANEWS) – Medallion Financial Corp. (MFIN), Palomar Holdings (PLMR), Arthur J. Gallagher & Co. (AJG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Medallion Financial Corp. (MFIN)
35.6% sales growth and 15.82% return on equity
Medallion Financial Corp., together with its subsidiaries, operates as a finance company in the United States. The company operates through four segments: Recreation Lending, Home Improvement Lending, Commercial Lending, and Medallion Lending. It provides loans that finance consumer purchases of recreational vehicles, boats, and trailers; consumer home improvements; commercial businesses; and taxi medallions to individuals, and small to mid-size businesses. The company also offers commercial loans for purchase of equipment and related assets necessary to open a new business, or purchase or improvement of an existing business; and medallion loans. In addition, it provides debt, mezzanine, and equity investment capital to companies in various industries; and raises deposits and conducts other banking activities. Medallion Financial Corp. was incorporated in 1995 and is headquartered in New York City, New York.
Earnings Per Share
As for profitability, Medallion Financial Corp. has a trailing twelve months EPS of $2.34.
PE Ratio
Medallion Financial Corp. has a trailing twelve months price to earnings ratio of 4.03. Meaning, the purchaser of the share is investing $4.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.82%.
Volume
Today’s last reported volume for Medallion Financial Corp. is 97422 which is 55.71% above its average volume of 62565.
2. Palomar Holdings (PLMR)
23.6% sales growth and 18.26% return on equity
Palomar Holdings, Inc., an insurance holding company, provides specialty property insurance to residential and commercial customers. The company offers personal and commercial specialty property insurance products, including residential and commercial earthquake, commercial all risk, specialty homeowners, inland marine, Hawaii hurricane, and residential flood, as well as other products, such as assumed reinsurance, commercial flood, real estate error and omission, and real estate investor products. It markets and distributes its products through retail agents, wholesale brokers, program administrators, and carrier partnerships. The company was formerly known as GC Palomar Holdings. Palomar Holdings, Inc. was incorporated in 2013 and is headquartered in La Jolla, California.
PE Ratio
Palomar Holdings has a trailing twelve months price to earnings ratio of 20.89. Meaning, the purchaser of the share is investing $20.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.26%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.7%, now sitting on 359.16M for the twelve trailing months.
3. Arthur J. Gallagher & Co. (AJG)
15.7% sales growth and 11.92% return on equity
Arthur J. Gallagher & Co., together with its subsidiaries, provides insurance and reinsurance brokerage, consulting, and third-party property/casualty claims settlement and administration services to businesses and organizations worldwide. It operates in Brokerage and Risk Management segments. The Brokerage segment offers retail and wholesale insurance and reinsurance brokerage services; assists retail brokers and other non-affiliated brokers in the placement of specialized and hard-to-place insurance; and acts as a brokerage wholesaler, managing general agent, and managing general underwriter for distributing specialized insurance coverages to underwriting enterprises. This segment also performs activities, including marketing, underwriting, issuing policies, collecting premiums, appointing and supervising other agents, paying claims, and negotiating reinsurance; and offers services in the areas of insurance and reinsurance placement, risk of loss management, and management of employer sponsored benefit programs. The Risk Management segment provides contract claim settlement and administration services; and claims management, loss control consulting, and insurance property appraisal services. The company offers its services through a network of correspondent brokers and consultants. It serves commercial, industrial, public, religious, and not-for-profit entities, as well as underwriting enterprises. The company was founded in 1927 and is headquartered in Rolling Meadows, Illinois.
Earnings Per Share
As for profitability, Arthur J. Gallagher & Co. has a trailing twelve months EPS of $5.2.
PE Ratio
Arthur J. Gallagher & Co. has a trailing twelve months price to earnings ratio of 42.93. Meaning, the purchaser of the share is investing $42.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.92%.
4. iRadimed Corporation (IRMD)
13.8% sales growth and 22.62% return on equity
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Earnings Per Share
As for profitability, iRadimed Corporation has a trailing twelve months EPS of $1.29.
PE Ratio
iRadimed Corporation has a trailing twelve months price to earnings ratio of 32.35. Meaning, the purchaser of the share is investing $32.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.62%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.1%, now sitting on 62.97M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
iRadimed Corporation’s EBITDA is 7.64.
Moving Average
iRadimed Corporation’s worth is above its 50-day moving average of $41.22 and under its 200-day moving average of $43.66.
Sales Growth
iRadimed Corporation’s sales growth is 15.2% for the present quarter and 13.8% for the next.
5. First Industrial Realty Trust (FR)
10.9% sales growth and 10.92% return on equity
First Industrial Realty Trust, Inc. (NYSE: FR) is a leading fully integrated owner, operator, and developer of industrial real estate with a track record of providing industry-leading customer service to multinational corporations and regional customers. Across major markets in the United States, our local market experts manage, lease, buy, (re)develop, and sell bulk and regional distribution centers, light industrial, and other industrial facility types. In total, we own and have under development approximately 64.1 million square feet of industrial space as of September 30, 2020.
Earnings Per Share
As for profitability, First Industrial Realty Trust has a trailing twelve months EPS of $2.02.
PE Ratio
First Industrial Realty Trust has a trailing twelve months price to earnings ratio of 24. Meaning, the purchaser of the share is investing $24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.92%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 27, 2023, the estimated forward annual dividend rate is 1.28 and the estimated forward annual dividend yield is 2.64%.
Moving Average
First Industrial Realty Trust’s value is above its 50-day moving average of $44.86 and under its 200-day moving average of $50.27.
Sales Growth
First Industrial Realty Trust’s sales growth is 8.1% for the present quarter and 10.9% for the next.
Volume
Today’s last reported volume for First Industrial Realty Trust is 1158550 which is 20.48% above its average volume of 961588.
6. Edwards Lifesciences (EW)
7.6% sales growth and 22.06% return on equity
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Earnings Per Share
As for profitability, Edwards Lifesciences has a trailing twelve months EPS of $2.34.
PE Ratio
Edwards Lifesciences has a trailing twelve months price to earnings ratio of 33.47. Meaning, the purchaser of the share is investing $33.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.06%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Edwards Lifesciences’s EBITDA is 7.01.
Volume
Today’s last reported volume for Edwards Lifesciences is 3646130 which is 21.66% below its average volume of 4654470.
Sales Growth
Edwards Lifesciences’s sales growth is 11% for the current quarter and 7.6% for the next.
Yearly Top and Bottom Value
Edwards Lifesciences’s stock is valued at $78.31 at 00:22 EST, way under its 52-week high of $94.87 and way higher than its 52-week low of $60.57.
